EUVIMEDEUVIMED entdecken
Crossref

Abhrak Bhasma alleviates the cyclophosphamide-induced lung damage via the NF-κB signalling pathway

Sandeep Saini, Rohit Kumar Gautam, Gourav Rohilla, Pratik Naxine, Itishree Dubey, Saima, Pinky Satija, Sapana Kushwaha

Respiratory Physiology & Neurobiology · 2026-08 · 344 · 104592

DOI: 10.1016/j.resp.2026.104592 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Respiratory Physiology & Neurobiology, 2026-08. Verfasst von Sandeep Saini und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli, (NIPER-R), Lucknow, UP 226002, Ind…. Hauptthemen laut MEDLINE: Cyclophosphamide, NF-kappa B, Signal Transduction, Lung Injury. Die Arbeit nennt 68 Literaturangaben. Gefördert von: Government of India Department of Pharmaceuticals, National Institute of Pharmaceutical Education and Research Raebareli, National Institute of Pharmaceutical Education and Research, Ahmedabad.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cyclophosphamide (CP) is a widely used alkylating chemotherapeutic and immunosuppressive agent that exerts its therapeutic effects through DNA crosslinking but is also associated with dose-limiting toxicities, including pulmonary toxicity mediated by oxidative stress, inflammation, and fibrotic remodelling. Abhrak Bhasma (AB), a classical Ayurvedic formulation, possesses antioxidant and anti-inflammatory properties. The present study aimed to evaluate the protective effects of AB against CP-induced lung injury in male BALB/c mice. CP administration resulted in significant decreases in body weight and lung weight increased lung weight and lung index, elevated oxidative stress, and marked histopathological alterations in lung tissue. Treatment with AB ameliorated these changes, as evidenced by improved body weight and normalization of lung parameters. AB reduced lipid peroxidation and restored endogenous antioxidant defences, including glutathione, superoxide dismutase, and catalase. Histopathological analysis demonstrated that AB attenuated alveolar wall thickening, inflammatory cell infiltration, collagen deposition, and elastin fibre accumulation, indicating reduced pulmonary inflammation and fibrotic remodelling. At the molecular level, AB suppressed the expression of phosphorylated IκB-α, phosphorylated NF-κB, and α-smooth muscle actin, suggesting inhibition of key inflammatory and profibrotic signalling pathways. In conclusion, these findings demonstrate that AB protects against CP-induced pulmonary toxicity through antioxidant, anti-inflammatory, and antifibrotic mechanisms, highlighting its therapeutic potential.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CyclophosphamideNF-kappa BSignal TransductionLung InjuryAnimalsMaleMiceMice, Inbred BALB COxidative StressLungDisease Models, AnimalAntioxidantsLipid PeroxidationGlutathione

Stichwörter der Autor:innen

Abhrak Bhasma (AB)Cyclophosphamide (CP)Inflammation and oxidative stressPulmonary toxicity

Substanzen

CyclophosphamideNF-kappa BAntioxidantsGlutathione

Autor:innen und Institutionen

  • Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli, (NIPER-R), Lucknow, UP 226002, India.
  • School of Advanced Chemical Sciences, Shoolini University of Biotechnology and Management Sciences, Solan, Himachal Pradesh 173229, India.
  • Department of Chemistry and Biochemistry, Thapar Institute of Engineering and Technology, Patiala, Punjab 147004, India.
  • Department of Pharmacology and Toxicology, National Institute of Pharmaceutical Education and Research, Raebareli, (NIPER-R), Lucknow, UP 226002, India. Electronic address: sapana.kushwaha@niperrbl.ac.in.

Förderung

  • Government of India Department of Pharmaceuticals
  • National Institute of Pharmaceutical Education and Research Raebareli
  • National Institute of Pharmaceutical Education and Research, Ahmedabad

Zitieren

APA

Saini, S., Gautam, R. K., Rohilla, G., Naxine, P., Dubey, I., Saima, Satija, P., & Kushwaha, S. (2026). Abhrak Bhasma alleviates the cyclophosphamide-induced lung damage via the NF-κB signalling pathway. Respiratory Physiology & Neurobiology, 344, 104592. https://doi.org/10.1016/j.resp.2026.104592

Vancouver

Saini S, Gautam RK, Rohilla G, Naxine P, Dubey I, Saima, et al. Abhrak Bhasma alleviates the cyclophosphamide-induced lung damage via the NF-κB signalling pathway. Respiratory Physiology & Neurobiology. 2026;344:104592. doi:10.1016/j.resp.2026.104592

BibTeX
@article{Saini2026,
  author = {Saini, Sandeep and Gautam, Rohit Kumar and Rohilla, Gourav and Naxine, Pratik and Dubey, Itishree and Saima and Satija, Pinky and Kushwaha, Sapana},
  title = {Abhrak Bhasma alleviates the cyclophosphamide-induced lung damage via the NF-κB signalling pathway},
  journal = {Respiratory Physiology & Neurobiology},
  year = {2026},
  volume = {344},
  pages = {104592},
  doi = {10.1016/j.resp.2026.104592}
}
Kostenlos starten →